Targeting SUMO2 reverses aberrant epigenetic rewiring driven by SS18::SSX fusion oncoproteins and impairs sarcomagenesis
Rema Iyer(Discovery Institute), Aniruddha J. Deshpande(Sanford Burnham Prebys Medical Discovery Institute)
Cited by 1
Related Papers
A JAK/STAT-Mediated Inflammatory Signaling Cascade Drives Oncogenesis In AF10-Rearranged AML
|bioRxiv (Cold Spring Harbor Laboratory)|2020|3
High Density Domain-Focused CRISPR Screens Reveal Novel Epigenetic Regulators of <i>HOX/MEIS</i> Activation in Acute Myeloid Leukemia
|bioRxiv (Cold Spring Harbor Laboratory)|2022|1